Argenx
ARGX
#456
Rank
S$67.07 B
Marketcap
S$1,084
Share price
-0.10%
Change (1 day)
23.04%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): S$11.52

According to Argenx 's latest financial reports the company's current EPS (TTM) is S$11.30. In 2024 the company made an earnings per share (EPS) of S$17.73 an increase over its 2023 EPS that were of S-$6.57.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$11.52-35.01%
2024S$17.73-369.77%
2023S-$6.57-60.46%
2022S-$16.6263.33%
2021S-$10.18-40.37%
2020S-$17.07183.47%
2019S-$6.02123.09%
2018S-$2.7054.93%
2017S-$1.7414.07%
2016S-$1.5313.05%
2015S-$1.35-36.34%
2014S-$2.12209.04%
2013S-$0.69-33.99%
2012S-$1.04185.59%
2011S-$0.36